Karooooo Ltd. Ordinary Shares (KARO)

FairStock Score: 69/100 — STEADY

Key Financials

Strengths

• Generates $620 million in annual free cash flow (40.6% yield on market cap)
• Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
• High return on equity of 33.6% demonstrating efficient capital deployment
• Conservative balance sheet with debt-to-equity of just 0.20, providing financial flexibility
• Revenue growth of 21.6% demonstrates strong top-line momentum

Concerns

• Altman Z-Score of 1.5 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Karooooo Ltd. Ordinary Shares is a micro-cap technology company valued at $1.5 billion. The business generates $5.3 billion in annual revenue with a 5.0% net margin and $620 million in free cash flow. From a quality standpoint, Karooooo shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and distressed Altman Z-Score of 1.5 warrants caution. On valuation, the stock is reasonably priced at 24.7x earnings, with a modest 28% margin of safety vs Graham Number. Growth dynamics show revenue growing at 21.6% and profit growth of 11.3%. The 4.7% dividend yield adds an income component for patient holders. Our composite FairStock Score of 69/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Karooooo's 22% revenue growth trajectory could accelerate as it captures additional market share in the technology sector. With $620 million in annual free cash flow (40.6% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the technology space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer